SGLT-2 Inhibition : A Glucuretic Treatment Option for Your Adult Patients with Type Diabetes

3043700 9/14

Please join us

SGLT-2 Inhibition: A Glucuretic Treatment Option for Your Adult Patients with Type 2 Diabetes

Speaker

Dr. S. Caleb Kim,

Family Medicine Center of Amarillo

Place

Grace Restaurant

777 Main Street

Fort Worth, TX, 76102

Date

05/24/2018

Time

06:30 PM – 08:30 PM

Central Standard Time

RSVP to

Rob Morris at

972.768.2173 or robert.morris@astrazeneca.com by

5/21/2018

AstraZeneca will comply with any and all federal or state reporting requirements regarding any value or expense associated with this event. AstraZeneca fully supports and abides by the PhRMA Code on interactions with health care professionals (HCPs). This program is open only to HCP invitees. AstraZeneca will not accommodate attendance of a spouse or other guest of any HCP attendee, nor will AstraZeneca pay for transportation or parking costs of attendees.

If you are a prescriber and/or a Federal, State, or institution employee, you may be subject to laws, regulations or rules which prohibit or limit your receipt of gifts, meals or items of value. We ask that you comply with any such restrictions. AstraZeneca will not recommend, endorse, or support the submission of this promotional program for CE credits.